| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/22/2008 | CA2414054C Patch applicator |
| 07/22/2008 | CA2396145C Osmotic device containing pseudoephedrine and an h1 antagonist |
| 07/22/2008 | CA2366922C Formulations for detecting asthma |
| 07/22/2008 | CA2326828C Stent with smooth ends |
| 07/22/2008 | CA2297021C Non-adherent superabsorbent wound dressing |
| 07/22/2008 | CA2283830C Composition for forming solid particles |
| 07/22/2008 | CA2278328C Antifungal nail lacquer and method using same |
| 07/22/2008 | CA2272406C Flat transdermal medicated self-adhesive patch |
| 07/22/2008 | CA2244205C Methods and compositions for enhancing the bioadhesive properties of polymers |
| 07/22/2008 | CA2238661C Killer t cell activator and use thereof |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2198916C Delivery of solid drug compositions |
| 07/22/2008 | CA2061579C Cystic fibrosis transmembrane conductance regulator (cftr) protein |
| 07/17/2008 | WO2008086492A1 Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment |
| 07/17/2008 | WO2008086486A1 Porous objects having immobilized encapsulated biomolecules |
| 07/17/2008 | WO2008086400A2 Sirtuin-activating compounds of enhanced bioavailability |
| 07/17/2008 | WO2008086358A1 Skin wound healing compositions and methods of use thereof |
| 07/17/2008 | WO2008086341A1 Methods. compositions, and formulations for preventing or reducing adverse effects in a patient |
| 07/17/2008 | WO2008086330A2 Formulations of deacetylase inhibitors |
| 07/17/2008 | WO2008086285A1 Eye medication delivery system |
| 07/17/2008 | WO2008086176A2 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| 07/17/2008 | WO2008085765A2 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 07/17/2008 | WO2008085711A1 Synergy of sodium channel blockers and calcium channel blockers |
| 07/17/2008 | WO2008085691A2 Multifunctional supramolecular hydrogels as biomaterials |
| 07/17/2008 | WO2008085556A2 Surfactant-free nanoparticles for drug delivery |
| 07/17/2008 | WO2008085484A2 Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid |
| 07/17/2008 | WO2008085310A2 Effervescent formulations of florfenicol for addition in drinking water systems |
| 07/17/2008 | WO2008085281A1 Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
| 07/17/2008 | WO2008084828A1 Method for producing coenzyme q10 particle |
| 07/17/2008 | WO2008084823A1 Brown coating composition and method for preparation thereof |
| 07/17/2008 | WO2008084805A1 Composition for external use |
| 07/17/2008 | WO2008084676A1 Pharmaceutical composition comprising porous dry matrix |
| 07/17/2008 | WO2008084533A1 Therapeutic agent for meniere’s disease |
| 07/17/2008 | WO2008084504A2 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/17/2008 | WO2008084312A2 Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| 07/17/2008 | WO2008084247A1 An encoded microsphere |
| 07/17/2008 | WO2008083561A1 Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof |
| 07/17/2008 | WO2008083542A1 Multiple modified derivatives of gelatin and crosslinked material thereof |
| 07/17/2008 | WO2008083508A1 Medically active plaster |
| 07/17/2008 | WO2008065097A3 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 07/17/2008 | WO2008064815A3 Preparation for transdermally administering galanthamine |
| 07/17/2008 | WO2008054412A3 Method and apparatus for forming chromonic nanoparticles |
| 07/17/2008 | WO2008045242A3 Implantable devices and methods for treating sinusitis and other disorders |
| 07/17/2008 | WO2008043167A8 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 07/17/2008 | WO2008037716A3 Pharmaceutical compositions comprising nilotinib or its salt |
| 07/17/2008 | WO2008032183A3 Rapidly disintegrating dosage form |
| 07/17/2008 | WO2008021133A3 Osmotic delivery systems and piston assemblies |
| 07/17/2008 | WO2008013833A3 Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles |
| 07/17/2008 | WO2008007234A3 Method and microcapsules for improving organoleptic properties |
| 07/17/2008 | WO2007146954A3 Suppository for hemorrhoid treatment |
| 07/17/2008 | WO2007123993A3 Niosome-hydrogel drug delivery |
| 07/17/2008 | WO2007121288A3 Drug depot implant designs and methods of implantation |
| 07/17/2008 | WO2007106182A3 Process for making pharmaceutical compositions with a transient plasticizer |
| 07/17/2008 | WO2007080149A9 Treatment of stressed patients |
| 07/17/2008 | WO2007075980A8 Lansoprazole orally disintegrating tablets |
| 07/17/2008 | WO2007057763A3 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
| 07/17/2008 | WO2006002038A3 Immunostimulatory oligonucleotide multimers |
| 07/17/2008 | WO2001060998A9 Small oligonucleotides with anti-tumor activity |
| 07/17/2008 | US20080172044 Drug Delivery Apparatus and Method for Automatically Reducing Drug Dosage |
| 07/17/2008 | US20080172043 Microchip reservoir devices using wireless transmission of power and data |
| 07/17/2008 | US20080172014 Extended therapeutic effect ocular implant treatments |
| 07/17/2008 | US20080171862 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 07/17/2008 | US20080171861 Method and medicament for inhibiting the expression of a given gene |
| 07/17/2008 | US20080171850 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 07/17/2008 | US20080171795 Novel Inter and Intra Multilamellar Vesicular Composition |
| 07/17/2008 | US20080171784 Stabilization of the pharmaceutical active solid substance atorvastatin (Lipitor) alone or in a mixture with other solid substances embedded in a surrounding gaseous mixturewhere a partial pressure of oxygen of at < 2 kPa is maintained; amorphous; blister-pack using an oxygen self-activating absorber |
| 07/17/2008 | US20080171091 Nanoparticulate compositions of immunosuppressive agents |
| 07/17/2008 | US20080171090 Dispersing core fine particles and coating layer comprising lipids or surfactants in liquid containing a polar solvent in which coating layer is soluble such that core fine particles are not dissolved; drug delivery of genes, DNA, RNA, oligonucleotides, plasmids, and/or siRNA; foods; antitumor agents |
| 07/17/2008 | US20080171089 Stable anti-nausea oral spray formulations and methods |
| 07/17/2008 | US20080171088 Particles of megestrol, megestrol acetate and a surface stabilizer |
| 07/17/2008 | US20080171087 Medical device: a polysiloxane substrate;a parylene layer contacting the surface of the substrate; and an elution control matrix of an active agent dispersed within a polymeric matrix |
| 07/17/2008 | US20080171086 Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same |
| 07/17/2008 | US20080171085 Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration |
| 07/17/2008 | US20080171084 And two lipidic excipients, an oily vehicle, and glyceroyl macrogolglycerides or polyethyleneglycol; increased bioavailability |
| 07/17/2008 | US20080171083 Pharmaceutical Compositions Comprising an Amphiphilic Starch |
| 07/17/2008 | US20080171082 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/17/2008 | US20080171081 Administering liposomes carrying phosphate-glycerol groups; inhibiting and/or reducing the progression of the T-cell function-mediated disorder; antiinflammatory |
| 07/17/2008 | US20080171080 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/17/2008 | US20080171079 Administering an immunogenic composition of Varicella-Zoster Virus gE, or immunogenic fragment, and a TH-1 adjuvant |
| 07/17/2008 | US20080171078 Uniformly sized liposomes |
| 07/17/2008 | US20080171077 Method and apparatus for making uniformly sized particles |
| 07/17/2008 | US20080171076 Dermatological and/or Cosmetic Composition Containing Polypeptides |
| 07/17/2008 | US20080171075 Transdermal composition; amitriptyline, clonidine, ketamine, an anti-inflammatory, lecithin isopropyl palmitate oil; analgesic |
| 07/17/2008 | US20080171071 Novel IGF-1 composition and its use |
| 07/17/2008 | US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity |
| 07/17/2008 | US20080171029 Beauty mask |
| 07/17/2008 | US20080170998 Preventing adhesion of Porphyromonas gingivalis as periodontopathic bacterium to oral tissue using oligo or polypeptide of arginine-histidine |
| 07/17/2008 | US20080170997 Compositions for the treatment and prevention of cancer |
| 07/17/2008 | US20080170996 Administering a microbial lysate by aerosol inhalation; for immunocomprised patients, enhancing innate immunity, attenuate respiratory infection |
| 07/17/2008 | US20080170995 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/17/2008 | US20080168921 Method for making device for controlled reservoir opening by electrothermal ablation |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE202008001950U1 Nothilfeset für die Behandlung von Quallenvernesselungen Nothilfeset for the treatment of Quallenvernesselungen |
| 07/17/2008 | DE202006020168U1 Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten A pharmaceutical formulation for the manufacture of rapidly disintegrating tablets |
| 07/17/2008 | DE102007001953A1 Microstructured film use as components in micro reaction systems, filtration media, optical element, matting layer, reducer or diffraction filter, is produced by printing micrometer size fluid structures using inkjet-printer |
| 07/17/2008 | CA2675123A1 Vegetarian microcapsules |
| 07/17/2008 | CA2674681A1 Medically active plaster for releasing an active compound that is liquid at room temperature |
| 07/17/2008 | CA2674610A1 Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment |
| 07/17/2008 | CA2674608A1 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | CA2673856A1 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |